-+ 0.00%
-+ 0.00%
-+ 0.00%

Lytix Biopharma Raises NOK80 Million via Private Placement, Retail Offer

MT Newswires·11/18/2026 00:24:21
Listen to the news
12:24 AM EST, 11/18/2026 (MT Newswires) -- Lytix Biopharma (LYTIX.OL) raised 80 million Norwegian kroner in a private placement and retail offering, the clinical-stage biotechnology company said Wednesday. The private placement raised 74.7 million kroner by allocating 9.34 million shares at 8 kroner apiece, while the retail offering raised an additional 5.3 million kroner. The proceeds will support preparations for a planned phase 3 study of ruxotemitide in neoadjuvant melanoma, the Aletta phase 2 study, development of LTX-401 toward phase 1, and general corporate purposes. Lytix also plans a subsequent offering of up to 15 million kroner at 8 kroner per share, targeting eligible existing shareholders who did not participate in the private placement or retail offering.